Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 3 March

Jessica Amir
March 3, 2020

Morning Bell 2 March

Jessica Amir
March 2, 2020

February Market Overview

Jessica Amir
February 28, 2020

Morning Bell 28 February

Jessica Amir
February 28, 2020

Morning Bell 27 February

Jessica Amir
February 27, 2020

Market Update 26 February

Jessica Amir
February 26, 2020

Morning Bell 25 February

Jessica Amir
February 25, 2020

Reporting season: Appen (ASX:APX)

Jessica Amir
February 24, 2020

Morning Bell 24 February

Paulina Peters
February 24, 2020

Weekly Wrap 21 February

Jessica Amir
February 21, 2020

Morning Bell 21 February

Jessica Amir
February 21, 2020